Evommune, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Evommune, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $732.00K, a 18200.00% increase year-over-year.
- Evommune, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Evommune, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $0.00.
- Evommune, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $4.00K.
- Evommune, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $6.00K, a 53.85% decline from fiscal 2024.
- Evommune, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $13.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $732.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $6.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-12-11 | $16.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $4.00K 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $1.00K 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $13.00K 10-K · filed 2026-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |